Which funds bought or sold ABT in Q3 2026?
Abbott Laboratories. 12 funds bought, 14 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$681M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- JPMorgan+$1.5B
- Capital Research+$798M
- T. Rowe Price+$379M
- AQR+$301M
- RBC+$270M
- Arrowstreet+$255M
- Morgan Stanley+$231M
- UBS+$200M
- Invesco+$178M
- AllianceBernstein+$121M
- Citadel−$682M
- Wells Fargo−$520M
- Marshall Wace−$504M
- Goldman Sachs−$392M
- Wellington−$361M
- Two Sigma−$308M
- Schwab−$248M
- Ameriprise−$206M
- Holocene−$191M
- Hudson Bay−$158M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (12)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| JPMorgan Bank & broker | Added+96.8% | +$1.5B | $3.0B |
| Capital Research Asset manager | Added+21.9% | +$798M | $4.4B |
| T. Rowe Price Asset manager | Added+1401.2% | +$379M | $406M |
| AQR Quant & multi-strategy | Added+72.7% | +$301M | $716M |
| RBC Bank & broker | Added+43.4% | +$270M | $891M |
| Arrowstreet Quant & multi-strategy | Added+23.7% | +$255M | $1.3B |
| Morgan Stanley Bank & broker | Added+8.8% | +$231M | $2.9B |
| UBS Bank & broker | Added+27.4% | +$200M | $927M |
| Invesco Asset manager | Added+20.5% | +$178M | $1.0B |
| AllianceBernstein Asset manager | Added+40.8% | +$121M | $417M |
| CPP Investments Sovereign & pension | Added+31% | +$78M | $330M |
| CalPERS Sovereign & pension | Added+30% | +$63M | $275M |
Sold (14)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Citadel Quant & multi-strategy | Trimmed-80.2% | −$682M | $168M |
| Wells Fargo Bank & broker | Trimmed-34.7% | −$520M | $980M |
| Marshall Wace Quant & multi-strategy | Trimmed-92% | −$504M | $44M |
| Goldman Sachs Bank & broker | Trimmed-23.6% | −$392M | $1.3B |
| Wellington Asset manager | Trimmed-44% | −$361M | $460M |
| Two Sigma Quant & multi-strategy | Trimmed-38.4% | −$308M | $495M |
| Schwab Index giant | Trimmed-4.2% | −$248M | $5.6B |
| Ameriprise Asset manager | Trimmed-19.4% | −$206M | $853M |
| Holocene Hedge fund | Trimmed-77.5% | −$191M | $55M |
| Hudson Bay Quant & multi-strategy | Trimmed-99.8% | −$158M | $292K |
| Millennium Quant & multi-strategy | Trimmed-41.8% | −$149M | $207M |
| Adage Hedge fund | Trimmed-46.7% | −$108M | $123M |
| Vanguard Index giant | Trimmed-2.2% | −$106M | $4.7B |
| Tudor Hedge fund | Trimmed-97.8% | −$71M | $2M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.